ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Alchemab Therapeutics Ltd

Alchemab Therapeutics Ltd is an active company incorporated on 14 August 2019 with the registered office located in London, Greater London. Alchemab Therapeutics Ltd was registered 6 years ago.
Status
Active
Active since incorporation
Company No
12156844
Private limited company
Age
6 years
Incorporated 14 August 2019
Size
Medium
Balance sheet is under £27M
Under 250 employees
Confirmation
Submitted
Dated 28 November 2024 (9 months ago)
Next confirmation dated 28 November 2025
Due by 12 December 2025 (3 months remaining)
Last change occurred 9 months ago
Accounts
Due Soon
For period 1 Jan ⟶ 31 Dec 2023 (12 months)
Accounts type is Group
Next accounts for period 31 December 2024
Due by 30 September 2025 (22 days remaining)
Learn more about Alchemab Therapeutics Ltd
Contact
Address
East Side Office 1.02
Kings Cross
London
N1C 4AX
United Kingdom
Address changed on 19 Oct 2021 (3 years ago)
Previous address was 55-56 Russell Square London WC1B 4HP England
Telephone
020 80784357
Email
Unreported
See All Contacts
People
Officers
6
Shareholders
28
Controllers (PSC)
1
Dame Catherine Elizabeth Bingham
Director • Venture Capitalist • British • Lives in UK • Born in Oct 1965
Andrew David Levin
Director • Managing Director • American • Lives in United States • Born in Nov 1976
Mr Young T. Kwon
Director • Chief Executive Officer • American • Lives in United States • Born in Jan 1972
Mr Kevin Lee
Director • Ceo • English • Lives in England • Born in Apr 1968
Jane Katharine Osbourn
Director • Scientist / Chief Executive Officer • British • Lives in England • Born in Mar 1966
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
SV Health Investors UK Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Pulmocide Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Bicyclerd Limited
Mr Kevin Lee is a mutual person.
Active
Autifony Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Sitryx Therapeutics Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Enara Bio Limited
Dame Catherine Elizabeth Bingham is a mutual person.
Active
Bicycle Therapeutics Plc
Mr Kevin Lee is a mutual person.
Active
Bicycletx Limited
Mr Kevin Lee is a mutual person.
Active
See All Mutual Companies
Brands
Alchemab Therapeutics
Alchemab Therapeutics focuses on developing antibody therapeutics for difficult-to-treat diseases by studying resilient individuals to understand how they overcome these diseases..
Financials
Net Assets, Total Assets & Total Liabilities (2020–2023)
Period Ended
31 Dec 2023
For period 31 Dec ⟶ 31 Dec 2023
Traded for 12 months
Cash in Bank
£13.33M
Increased by £3.12M (+31%)
Turnover
Unreported
Same as previous period
Employees
65
Increased by 9 (+16%)
Total Assets
£25.68M
Increased by £8.32M (+48%)
Total Liabilities
-£7.91M
Increased by £4.87M (+160%)
Net Assets
£17.77M
Increased by £3.45M (+24%)
Debt Ratio (%)
31%
Increased by 13.3% (+76%)
See 10 Year Full Financials
Latest Activity
Group Accounts Submitted
8 Months Ago on 3 Jan 2025
Confirmation Submitted
9 Months Ago on 29 Nov 2024
Jane Katharine Osbourn Appointed
12 Months Ago on 11 Sep 2024
Young T. Kwon Resigned
12 Months Ago on 11 Sep 2024
Confirmation Submitted
1 Year 9 Months Ago on 1 Dec 2023
Group Accounts Submitted
2 Years 1 Month Ago on 8 Aug 2023
Houman Ashrafian Resigned
2 Years 1 Month Ago on 26 Jul 2023
Dame Catherine Elizabeth Bingham Appointed
2 Years 1 Month Ago on 26 Jul 2023
Confirmation Submitted
2 Years 9 Months Ago on 8 Dec 2022
Group Accounts Submitted
3 Years Ago on 15 Jul 2022
Get Alerts
Get Credit Report
Discover Alchemab Therapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Statement of capital following an allotment of shares on 26 August 2025
Submitted on 28 Aug 2025
Statement of capital following an allotment of shares on 3 July 2025
Submitted on 31 Jul 2025
Particulars of variation of rights attached to shares
Submitted on 28 Jul 2025
Change of share class name or designation
Submitted on 28 Jul 2025
Memorandum and Articles of Association
Submitted on 16 Jul 2025
Resolutions
Submitted on 16 Jul 2025
Statement of capital following an allotment of shares on 17 April 2025
Submitted on 29 Apr 2025
Statement of capital following an allotment of shares on 3 January 2025
Submitted on 10 Jan 2025
Group of companies' accounts made up to 31 December 2023
Submitted on 3 Jan 2025
Statement of capital following an allotment of shares on 9 December 2024
Submitted on 11 Dec 2024
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs